Sign in

CIK 0001620463

  • Non-accelerated filer
  • Smaller reporting company

LeonaBio, Inc.

Sign in to watch
Ticker
LONA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
453368487
Phone
+1 425-620-8501
Business address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Former names
Athira Pharma, Inc., M3 Biotechnology, Inc.
Open-market buys, last 90 days
$9,919,161,281
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Portman David J. +$9.9B 10% owner 1 filing
Date Insider Transaction Shares Price Value Owned after
2020-09-22 Litton Mark James Chief Operating Officer Conversion · Series B-1 Preferred Stock −6,563 0
2020-09-22 Litton Mark James Chief Operating Officer Conversion · Series B-1 Preferred Stock −6,563 0
2020-09-22 Litton Mark James Chief Operating Officer Conversion · Series B-1 Preferred Stock −6,563 0
2020-09-22 PERCEPTIVE ADVISORS LLC 10% owner Conversion +1,644,785 2,055,981
2020-09-22 PERCEPTIVE ADVISORS LLC 10% owner Purchase +1,058,824 $17.00 $18.0M 3,114,805
2020-09-22 PERCEPTIVE ADVISORS LLC 10% owner Conversion · Series B Preferred Stock −1,644,785 0
2020-09-18 RTW INVESTMENTS, LP 10% owner Conversion +1,535,131 1,918,913
2020-09-18 RTW INVESTMENTS, LP 10% owner Purchase +750,000 $17.00 $12.8M 2,668,913
2020-09-18 RTW INVESTMENTS, LP 10% owner Conversion · Series B Convertible Preferred Stock −1,535,131 0

Page 18 of 18 · 349 trades